To conduct a survey examining issues relating to implementation of the diabetes NSF (National Service Framework) in primary care.
Methods
Fifty-two general practices were sent a questionnaire (14 questions) to investigate issues relating to implementation of the NSF for diabetes.
Results
A completed questionnaire was returned by 32 (≥ 60%) of practices. Of these, 30 (93.7%) had a practice register for diabetes, 18 (56.2%) had a screening policy for undiagnosed diabetes and 23 (71.9%) had specific diabetes clinics (SDC).
The practice nurse was at the front line of diabetes care, with the general practitioner, podiatrist and dietitian playing an increased role when patients had uncontrolled risk factors, or complications. In SDC lack of funding, specialist personnel and time were the main barriers to implementing the diabetes NSF.
In most practices holding SDC, patients with diabetes (65.2%) were not seen in the same clinics as patients with other cardiovascular risk problems, but without diabetes (34.8%). In those general practices not holding SDC, the majority reported they did not wish to develop these clinics (60%), due mainly to time restrictions. Only a minority (24%) of general practices referred patients with psychological problems, related to diabetes, to clinical psychology services.
Conclusion
Many general practices lack the necessary infrastructure to deliver comprehensive diabetes care and will struggle, without additional resources, to meet standards of care required, following NSF implementation.
Department of Health.National Service Framework for Diabetes: Standards. London: Department of Health; 2001.
2.
Department of Health.National Service Framework for Diabetes: Delivery Strategy. London: Department of Health; 2003.
3.
Davies MJA National Service Framework for diabetes. Br J Diabetes Vasc Dis2001;1:123-5.
4.
Day C.The rising tide of type 2 diabetes. Br J Diabetes Vasc Dis2001;1:37-43.
5.
Dixon S., Currie CJ, Peters JRThe cost of diabetes: time for a different approach. Diabet Med2000;17:820-2.
6.
The Audit Commission.Testing times: a review of diabetes services in England and Wales 2000. Department Of Health Publication, London, U.K.
7.
Cavn D., Fosbury J., Trigwell P.Psychology in diabetes - why bother. Pract Diab Int2001;18:228-9.
8.
New JP, Roxburgh MA, Vaughan NJ, Wallace C., Elliott P., Young RJMeasuring differences in the provision of diabetes care. Diabetes Nutr Metab2001;14:104-07.
9.
UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet1998;352:837-53.
10.
UK Prospective Diabetes Study (UKPDS) Group.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38. BMJ1998;317:703-13.
11.
The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators.Effects of ramapril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet2000;355:253-9.
12.
Scandinavian Simvastatin SurvivalStudy Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvistatin Survival Study. Lancet1994;344:1383-9.
13.
Sanmugunathan PS, Ghahramani P., Jackson PR et al. Aspirin for primary prevention of coronary heart disease; safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart2000;85:265-71.
14.
Wareham NJ, Griffin SJShould we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ2001;322:986-8.
15.
Lawrence JM , Bennett P., Young A., Robinson AMScreening for diabetes Ein general practice: cross sectional population study. BMJ2001 ;323:548-51.
16.
Borch-Johnsen K., Lauritzen T., Glumer C., Sandbaek A.Screening for Type 2 diabetes-should it be now?Diabet Med2003;20:175-81.
17.
Buckley MGFocus on diabetes care offers a challenge to practice nurses. Nursing Times2003;99:14.
18.
Sampson MJ, Shepstone L., Greenwood RH et al. An integrated mobile foot and retinal screening programme for people with type 2 diabetes managed in primary care. Diabet Med2002;19:74-6.
19.
Mykkanen L.Prevention of coronary heart disease in type 2 diabetes. Int J Clin Pract (Suppl)2000 ;113:40-5.
20.
Rouse A., Adab P.Is population coronary heart disease risk screening justified? A discussion of the NSF for coronary heart disease (Standard 4). Br J Gen Pract2001;51:834-7.
21.
Buckley MG, Marcus NJ, Yacoub MHCardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Clin Sci1999;97:689-95.
22.
Buckley MG, Jenkins GH, Mitchell AG, Yacoub MH, Singer DRJ.Circulating C-Type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathy . Clin Sci2000;99:467-72.
23.
Rubin RR, Peyrot M.Psychological issues and treatments for people with diabetes. J Clin Psychol2001;57:457-78.
24.
Snoek FJ, Skinner TCPsychological counselling in problematic diabetes: does it help. Diabet Med2002;19:265-73.
25.
McGough N.Dietetic shortfalls that the National Service Framework for diabetes will need to address. J Hum Nutr Dietet2001 ;14:485-6.
26.
Pierce M., Agarwal G., Ridout D.A survey of diabetes care in general practice in England and Wales . Br J Gen Pract2000;50:542-5.
27.
Farooqi A., Dodd L., Stribling B., Khunti K., Davies MJA base line survey of diabetes service provision in a city primary care trust . Diabet Med2003;20(suppl 2):Abs72.
28.
Moore W.NHS to receive an extra £40 billion over the next five years. BMJ2002:324:993.
29.
Hippisley-Cox J., Pringle M.General practice workloads implications of the national service framework for coronary heart disease: cross sectional survey. BMJ2001;323:269-70.
